Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-12-15 Nicholson John SVP & Chief Operating Officer Grant or award · Stock Option +65,000 65,000
2017-12-15 Labrucherie Gil M SVP & Chief Financial Officer Grant or award +26,000 103,216
2017-12-15 Labrucherie Gil M SVP & Chief Financial Officer Grant or award · Stock Option +65,000 65,000
2017-12-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award +15,000 83,136
2017-12-15 Hora Maninder SVP Pharma Dev & Mfg Ops Grant or award · Stock Option +37,500 37,500
2017-12-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award +26,000 69,820
2017-12-15 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +65,000 65,000
2017-12-13 ROBIN HOWARD W President & CEO Exercise or conversion +83,333 $11.34 $945K 272,768
2017-12-13 ROBIN HOWARD W President & CEO Sale −83,333 $55.69 $4.6M 189,435
2017-12-13 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −83,333 83,333
2017-11-16 Thomsen Jillian B. SVP & Chief Accounting Officer Returned to the company −5,289 $44.23 $234K 60,549
2017-11-16 ROBIN HOWARD W President & CEO Returned to the company −18,069 $44.23 $799K 189,435
2017-11-16 Nicholson John SVP & Chief Operating Officer Returned to the company −6,620 $44.23 $293K 246,536
2017-11-16 Labrucherie Gil M SVP & Chief Financial Officer Returned to the company −6,698 $44.23 $296K 76,716
2017-11-16 Hora Maninder SVP Pharma Dev & Mfg Ops Returned to the company −5,597 $44.23 $248K 67,636
2017-11-16 Gergel Ivan P. SVP & Chief Medical Officer Returned to the company −5,022 $44.23 $222K 56,553
2017-11-16 Doberstein Stephen K SVP & Chief Scientific Officer Returned to the company −4,782 $44.23 $212K 43,820
2017-11-15 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award +15,000 65,838
2017-11-15 Thomsen Jillian B. SVP & Chief Accounting Officer Grant or award · Stock Option +37,500 37,500
2017-11-15 ROBIN HOWARD W President & CEO Grant or award +55,000 207,504

Page 37 of 43 · 847 trades